[1] Hua K, Pan Y, Fang J, et al., 2024, Integrating social, climate and environmental changes to confront accelerating global aging. BMC Public Health, 24(1): 2838.

[2] Luo Y, Su B, Zheng X, 2021, Trends and challenges for population and health during population aging—China, 2015–2050. China CDC Weekly, 3(28): 593.

[3] Fang EF, Fang Y, Chen G, et al., 2025, Adapting health, economic and social policies to address population aging in China. Nature Aging, 1-12.

[4] Theodorakis N, Feretzakis G, Kreouzi M, et al., 2025, Envisioning the Future of Health Informatics and Digital Health. IOS Press, 473-477.

[5] Czyżewski Ł, Dudziński Ł, Silczuk A, et al., 2026, HEMS and the challenges of an aging population: a nationwide study of interventions. Frontiers in Public Health, 14: 1746463.

[6] Matsuda S, 2019, Health policy in Japan – current situation and future challenges. JMA Journal, 2(1): 1-10.

[7] Aximu N, Yimingniyazi B, Lin D, et al., 2025, Human resources in long-term care for older adults in China: Challenges amid population aging. BioScience Trends, 19(6): 626-640.

[8] Ruperez C, Madeo F, de Cabo R, et al., 2025, Obesity accelerates cardiovascular ageing. European Heart Journal, 46(23): 2161-2185.

[9] Barber TM, Kabisch S, Pfeiffer AF, et al., 2025, Optimised skeletal muscle mass as a key strategy for obesity management. Metabolites, 15(2): 85.

[10] Zhou Q, Zhu Y, Guo Q, et al., 2025, Association between sarcopenia and falls, fractures, hospital readmission, and all-cause mortality in older adults with endocrine disorders: a longitudinal study of aging in China. BMC Musculoskeletal Disorders, 26(1): 842.

[11] Heber D, Ingles S, Ashley JM, et al., 1996, Clinical detection of sarcopenic obesity by bioelectrical impedance analysis. The American Journal of Clinical Nutrition, 64(3): 472S-477S.

[12] Wannamethee SG, Atkins JL, 2015, Muscle loss and obesity: the health implications of sarcopenia and sarcopenic obesity. Proceedings of the Nutrition Society, 74(4): 405-412.

[13] Baumgartner RN, 2000, Body composition in healthy aging. Annals of the New York Academy of Sciences, 904(1): 437-448.

[14] Donini LM, Busetto L, Bischoff SC, et al., 2022, Definition and diagnostic criteria for sarcopenic obesity: ESPEN and EASO consensus statement. Obesity Facts, 15(3): 321-335.

[15] Şengül Ayçiçek G, Okyar Baş A, Karabulut E, et al., 2025, Prevalence, diagnosis and treatment of sarcopenic obesity in older adults: a systematic review and a meta-analysis. Acta Clinica Belgica, 80(6): 226-249.

[16] Luo Y, Shu L, Wang Y, et al., 2025, Sarcopenic obesity and risk of cardio-cerebrovascular disease and mortality: a systematic review and meta-analysis: Epidemiology and Population Health. International Journal of Obesity, 49(12): 2406-2414.

[17] Wang W, Fang F, Wang T, et al., 2025, The impact of sarcopenic obesity on the prevalence and prognosis of non-metastatic colorectal cancer: a systematic review and meta-analysis. Clinical Nutrition ESPEN.

[18] Park MJ, Choi KM, 2023, Interplay of skeletal muscle and adipose tissue: sarcopenic obesity. Metabolism, 144: 155577.

[19] Jang SY, Choi KM, 2025, Impact of adipose tissue and lipids on skeletal muscle in sarcopenia. Journal of Cachexia, Sarcopenia and Muscle, 16(4): e70000.

[20] Axelrod CL, Dantas WS, Kirwan JP, 2023, Sarcopenic obesity: emerging mechanisms and therapeutic potential. Metabolism, 146: 155639.

[21] Fan S, Yu Y, Wei Y, et al., 2025, Targeting the mTOR-mitochondrial function axis: Calcitriol attenuates sarcopenic obesity with lipid dysregulation etiology. Free Radical Biology and Medicine.

[22] Jones HG, Kopinke D, Meyer GA, 2025, Intramuscular adipose tissue: from progenitor to pathology. American Journal of Physiology-Cell Physiology, 329(4): C1268-C1282.

[23] Zhang T, Li J, Li X, et al., 2023, Intermuscular adipose tissue in obesity and related disorders: cellular origins, biological characteristics and regulatory mechanisms. Frontiers in Endocrinology, 14: 1280853.

[24] Sachs S, Zarini S, Kahn DE, et al., 2019, Intermuscular adipose tissue directly modulates skeletal muscle insulin sensitivity in humans. American Journal of Physiology-Endocrinology and Metabolism.

[25] Zhan P, Yan SB, Liu Y, et al., 2026, The Role of Fibro/adipogenic Progenitors (FAPs) in Sarcopenia: Mechanisms and Potential Therapeutic Strategies. Stem Cell Reviews and Reports, 1-29.

[26] Li CW, Yu K, Shyh‐Chang N, et al., 2022, Pathogenesis of sarcopenia and the relationship with fat mass: descriptive review. Journal of Cachexia, Sarcopenia and Muscle, 13(2): 781-794.

[27] Goodpaster BH, Bergman BC, Brennan AM, et al., 2023, Intermuscular adipose tissue in metabolic disease. Nature Reviews Endocrinology, 19(5): 285-298.

[28] Shen KC, Collins KH, Ferey JL, et al., 2024, Excess intramyocellular lipid does not affect muscle fiber biophysical properties in mice or people with metabolically abnormal obesity. Diabetes, 73(8): 1266-1277.

[29] Yoshiko A, Maeda H, Takahashi H, et al., 2022, Importance of skeletal muscle lipid levels for muscle function and physical function in older individuals. Applied Physiology, Nutrition, and Metabolism, 47(6): 649-658.

[30] Wu H, Ballantyne CM, 2017, Skeletal muscle inflammation and insulin resistance in obesity. The Journal of Clinical Investigation, 127(1): 43-54.

[31] Komiya H, Mori Y, Yokose T, et al., 2006, Effect of intramuscular fat difference on glucose and insulin reaction in oral glucose tolerance test. Journal of Atherosclerosis and Thrombosis, 13(3): 136-142.

[32] Reiter DA, Bellissimo MP, Zhou L, et al., 2023, Increased adiposity is associated with altered skeletal muscle energetics. Journal of Applied Physiology, 134(5): 1083-1092.

[33] Biltz NK, Collins KH, Shen KC, et al., 2020, Infiltration of intramuscular adipose tissue impairs skeletal muscle contraction. The Journal of Physiology, 598(13): 2669-2683.

[34] Kong X, Yao T, Zhou P, et al., 2018, Brown adipose tissue controls skeletal muscle function via the secretion of myostatin. Cell Metabolism, 28(4): 631-643.e633.

[35] Montgomery MK, De Nardo W, Watt MJ, 2023, Exercise training induces depot-specific remodeling of protein secretion in skeletal muscle and adipose tissue of obese male mice. American Journal of Physiology-Endocrinology and Metabolism, 325(3): E227-E238.

[36] Sakaguchi M, 2025, Aging-Induced Dysfunction of Adipose Tissue and Skeletal Muscle and its link to Insulin Resistance. The Journal of Biochemistry, mvaf081.

[37] Pollak N, Janežič EG, Šink Ž, et al., 2025, Crosstalk Between Skeletal Muscle and Proximal Connective Tissues in Lipid Dysregulation in Obesity and Type 2 Diabetes. Metabolites, 15(9): 581.

[38] Wang D, Zheng X, Yang Z, et al., 2026, High-fat diet exacerbates skeletal muscle mass loss via Nrf2/Prdx6 pathway in sarcopenic obesity mice. The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 81(3): glaf271.

[39] Dantas WS, Zunica ER, Heintz EC, et al., 2022, Mitochondrial uncoupling attenuates sarcopenic obesity by enhancing skeletal muscle mitophagy and quality control. Journal of Cachexia, Sarcopenia and Muscle, 13(3): 1821-1836.

[40] Russ DW, Manickam R, Tipparaju SM, 2025, Targeting intramyocellular lipids to improve aging muscle function. Lipids in Health and Disease, 24(1): 197.

[41] Kitessa SM, Abeywardena MY, 2016, Lipid-induced insulin resistance in skeletal muscle: the chase for the culprit goes from total intramuscular fat to lipid intermediates, and finally to species of lipid intermediates. Nutrients, 8(8): 466.

[42] Welch AA, Hayhoe RP, Cameron D, 2020, The relationships between sarcopenic skeletal muscle loss during ageing and macronutrient metabolism, obesity and onset of diabetes. Proceedings of the Nutrition Society, 79(1): 158-169.

[43] Pogodziński D, Ostrowska L, Smarkusz-Zarzecka J, et al., 2022, Secretome of adipose tissue as the key to understanding the endocrine function of adipose tissue. International Journal of Molecular Sciences, 23(4): 2309.

[44] Gu X, Wang L, Liu S, et al., 2023, Adipose tissue adipokines and lipokines: Functions and regulatory mechanism in skeletal muscle development and homeostasis. Metabolism, 139: 155379.

[45] Gkrinia EMM, Belančić A, 2025, The mechanisms of chronic inflammation in obesity and potential therapeutic strategies: A narrative review. Current Issues in Molecular Biology, 47(5): 357.

[46] Glass DJ, 2005, Skeletal muscle hypertrophy and atrophy signaling pathways. The International Journal of Biochemistry & Cell Biology, 37(10): 1974-1984.

[47] Takaguri A, 2018, Elucidation of a new mechanism of onset of insulin resistance: effects of statins and tumor necrosis factor-α on insulin signal transduction. Yakugaku Zasshi: Journal of the Pharmaceutical Society of Japan, 138(11): 1329-1334.

[48] Sakuma K, Yamaguchi A, 2013, Sarcopenic obesity and endocrinal adaptation with age. International Journal of Endocrinology, 2013(1): 204164.

[49] Kwon EY, Kim JW, Choi JY, et al., 2025, Setaria viridis Ethanol Extract Attenuates Muscle Loss and Body Fat Reduction in Sarcopenic Obesity by Regulating AMPK in High‐Fat Diet‐Induced Obese Mice. Food Science & Nutrition, 13(7): e70655.

[50] Kob R, Bollheimer LC, Bertsch T, et al., 2015, Sarcopenic obesity: molecular clues to a better understanding of its pathogenesis? Biogerontology, 16(1): 15-29.

[51] Dutra MT, Avelar BP, Souza VC, et al., 2017, Relationship between sarcopenic obesity‐related phenotypes and inflammatory markers in postmenopausal women. Clinical Physiology and Functional Imaging, 37(2): 205-210.

[52] Silveira Pereira S, Alvarez-Leite JI, 2014, Adipokines: biological functions and metabolically healthy obese profile. Journal of Receptor, Ligand and Channel Research, 7: 15-25.

[53] Farr OM, Gavrieli A, Mantzoros CS, 2015, Leptin applications in 2015: what have we learned about leptin and obesity? Current Opinion in Endocrinology, Diabetes and Obesity, 22(5): 353-359.

[54] Ren Y, Zhao H, Yin C, et al., 2022, Adipokines, hepatokines and myokines: focus on their role and molecular mechanisms in adipose tissue inflammation. Frontiers in Endocrinology, 13: 873699.

[55] Yang ZY, Chen WL, 2021, Examining the association between serum leptin and sarcopenic obesity. Journal of Inflammation Research, 14: 3481-3487.

[56] Kim Y, Song HJ, Kim DH, et al., 2026, Cross‐Sectional and Longitudinal Associations of Irisin and Adiponectin With Obesity, Sarcopenia and Sarcopenic Obesity. Journal of Cachexia, Sarcopenia and Muscle, 17(1): e70172.

[57] Tero-Vescan A, Degens H, Matsakas A, et al., 2025, Exercise-induced muscle–fat crosstalk: molecular mediators and their pharmacological modulation for the maintenance of metabolic flexibility in aging. Pharmaceuticals, 18(8): 1222.

[58] Lv J, Li Y, Shi S, et al., 2022, Skeletal muscle mitochondrial remodeling in heart failure: An update on mechanisms and therapeutic opportunities. Biomedicine & Pharmacotherapy, 155: 113833.

[59] Ge Y, Li S, Yao T, et al., 2023, Promotion of healthy adipose tissue remodeling ameliorates muscle inflammation in a mouse model of sarcopenic obesity. Frontiers in Nutrition, 10: 1065617.

[60] Udomsinprasert W, Manoy P, Yuktanandana P, et al., 2020, Decreased serum adiponectin reflects low vitamin D, high interleukin 6, and poor physical performance in knee osteoarthritis. Archivum Immunologiae et Therapiae Experimentalis, 68(3): 16.

[61] Hendrix A, Lippens L, Pinheiro C, et al., 2023, Extracellular vesicle analysis. Nature Reviews Methods Primers, 3(1): 56.

[62] Macleod M, Price J, Tsonou E, et al., 2026, Adipose‐Derived Extracellular Vesicles and Intercellular Crosstalk With Skeletal Muscle: Implications for Sarcopenic Obesity and Metabolic Dysregulation. Obesity Reviews, 27(1): 1-22.

[63] Qin M, Wang Y, Wang Z, et al., 2025, Adipose-derived small extracellular vesicle miR-146a-5p targets Fbx32 to regulate mitochondrial autophagy and delay aging in skeletal muscle. Journal of Nanobiotechnology, 23(1): 287.

[64] Wang D, Zhang X, Li Y, et al., 2022, Exercise-induced browning of white adipose tissue and improving skeletal muscle insulin sensitivity in obese/non-obese growing mice: do not neglect exosomal miR-27a. Frontiers in Nutrition, 9: 940673.

[65] Jeong I, Park S, Park J, et al., 2024, Adipose tissue-derived extracellular vesicles from obese mice suppressed splenocyte-mediated pancreatic cancer cell death. Food & Nutrition Research, 68: 10.29219/fnr.v29268.10545.

[66] Zhang L, Lv J, Wang C, et al., 2023, Myokine, a key cytokine for physical exercise to alleviate sarcopenic obesity. Molecular Biology Reports, 50(3): 2723-2734.

[67] Chen J, Yao X, Zhao Z, et al., 2025, Myokine-mediated muscle-organ interactions: Molecular mechanisms and clinical significance. Biochemical Pharmacology, 225: 117326.

[68] Orioli L, Thissen JP, 2025, Myokines as potential mediators of changes in glucose homeostasis and muscle mass after bariatric surgery. Frontiers in Endocrinology, 16: 1554617.

[69] Mahajan RD, Patra SK, 2013, Irisin, a novel myokine responsible for exercise induced browning of white adipose tissue. Indian Journal of Clinical Biochemistry, 28(1): 102-103.

[70] Boström P, Wu J, Jedrychowski MP, et al., 2012, A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature, 481(7382): 463-468.

[71] Basini G, Bussolati S, Grolli S, et al., 2022, Effects of the myokine irisin on stromal cells from swine adipose tissue. Biomolecules, 12(12): 1895.

[72] Mutlu HH, Koç Ada S, Uzunlulu M, et al., 2024, A comparison of brown fat tissue related hormone levels in metabolically healthy and unhealthy individuals with obesity. Endocrine, 86(3): 1025-1034.

[73] Knapp M, Supruniuk E, Górski J, 2023, Myostatin and the Heart. Biomolecules, 13(12): 1777.

[74] Yang M, Liu C, Jiang N, et al., 2023, Myostatin: a potential therapeutic target for metabolic syndrome. Frontiers in Endocrinology, 14: 1181913.

[75] Gavaldà-Navarro A, Villarroya J, Cereijo R, et al., 2022, The endocrine role of brown adipose tissue: An update on actors and actions. Reviews in Endocrine and Metabolic Disorders, 23(1): 31-41.

[76] Wang H, Guo S, Gao H, et al., 2024, Myostatin regulates energy homeostasis through autocrine-and paracrine-mediated microenvironment communication. The Journal of Clinical Investigation, 134(16).

[77] Sheptulina AF, Antyukh KY, Kiselev AR, et al., 2023, Possible mechanisms linking obesity, steroidogenesis, and skeletal muscle dysfunction. Life, 13(6): 1415.

[78] Tabone M, 2025, Muscle Mechanics in Metabolic Health and Longevity: The Biochemistry of Training Adaptations. BioChem, 5(4): 37.